CAS No.1380575-43-8 | LDK-378 Dihydrochloride

Introduction and application of CAS No.1380575-43-8 | LDK-378 dihydrochloride

LDK-378 dihydrochloride is a molecule that is used in the treatment of cancer. It inhibits tyrosine kinases, which are enzymes involved in cell signaling and growth. LDK-378 dihydrochloride has been shown to be effective against cancers that have developed resistance to other treatments, such as butyrate, chloroformate, nitro, and hydrochloric acid. It has been shown to inhibit the production of reactive oxygen species and tumor necrosis factor-α (TNF-α) in mouse models with lung cancer. The effective dose of ceritinib dihydrochloride is not yet known.

Synonyms:

Ceritinib dihydrochloride;

LDK378(Ceritinib)dihydrochloride;

LDK378dihydrochloride;

LDK378(dihydrochloride);

LDK3782Hcl;

Ceritinibdihydrochloride;

5-chloro-N2-(2-isopropoxy-5-Methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyriMidine-2,4-diaMinehydrochloride;

LDK378dihydrochloride,Ceritinibdihydrochloride

Specification of CAS No.1380575-43-8 | LDK-378 dihydrochloride

Package and transportation of Introduction and application of CAS No.1380575-43-8 | LDK-378 dihydrochloride

Package:0.1g,1g,5g,25g,100g,500g,1kg

Transportation: by courier/ by air/ by sea

Hot Tags: cas no.1380575-43-8 | ldk-378 dihydrochloride, China cas no.1380575-43-8 | ldk-378 dihydrochloride manufacturers, factory, Epsilon-polylysine, Proteinase K, Life Science Chemicals, Biochemicals, Spermidine, Sermaglutide